posted on 2025-02-06, 10:51authored byFreya Tyrer, Safoora Gharibzadeh, Clare Gillies, Claire Lawson, Ash Routen, Nazrul Islam, Cameron Razieh, Francesco Zaccardi, Tom Yates, Melanie J Davies, Christopher E Brightling, James D Chalmers, Annemarie B Docherty, Omer Elneima, Rachael A Evans, Neil J Greening, Victoria C Harris, Ewen M Harrison, Ling‐Pei Ho, Alex Horsley, Linzy Houchen‐Wolloff, Olivia C Leavy, Nazir I Lone, Michael Marks, Hamish JC McAuley, Krisnah Poinasamy, Jennifer K Quint, Betty Raman, Matthew Richardson, Ruth Saunders, Marco Sereno, Aarti Shikotra, Amish Singapuri, Louise V Wain, Kamlesh Khunti
<p dir="ltr">Background</p><p dir="ltr">People hospitalised for coronavirus disease 2019 (COVID‐19) have elevated incidence of diabetes. However, it is unclear whether this is due to shared risk factors, confounding or stress hyperglycaemia in response to acute illness.</p><p dir="ltr">Methods</p><p dir="ltr">We analysed a multicentre prospective cohort study (PHOSP‐COVID) of people ≥18 years discharged from NHS hospitals across the United Kingdom following COVID‐19. Individuals were included if they attended at least one research visit with a HbA1c measurement within 14 months of discharge and had no history of diabetes at baseline. The primary outcome was new onset diabetes (any type), as defined by a first glycated haemoglobin (HbA1c) measurement ≥6.5% (≥48 mmol/mol). Follow‐up was censored at the last HbA1c measurement. Age‐standardised incidence rates and incidence rate ratios (adjusted for age, sex, ethnicity, length of hospital stay, body mass index, smoking, physical activity, deprivation, hypertension, hyperlipidaemia/hypercholesterolaemia, intensive therapy unit admission, invasive mechanical ventilation, corticosteroid use and C‐reactive protein score) were calculated using Poisson regression. Incidence rates were compared with the control groups of published clinical trials in the United Kingdom by applying the same inclusion and exclusion criteria, where possible.</p><p dir="ltr">Results</p><p dir="ltr">Incidence of diabetes was 91.4 per 1000 person‐years and was higher in South Asian (incidence rate ratios [IRR] = 3.60; 1.77, 7.32; p < 0.001) and Black ethnic groups (IRR = 2.36; 1.07, 5.21; p = 0.03) compared with White ethnic groups. When restricted to similar characteristics, the incidence rates were similar to those in UK clinical trials data.</p><p dir="ltr">Conclusion</p><p dir="ltr">Diabetes incidence following hospitalisation for COVID‐19 is high, but it remains uncertain whether it is disproportionately higher than pre‐pandemic levels.</p>
Funding
National Institute for Health and Care Research
PHOSP-COVID Post-hospitalisation COVID-19 study: a national consortium to understand and improve long-term health outcomes
Tyrer F, Gharibzadeh S, Gillies C, et al. Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study. Diabetes Obes Metab. 2025; 27(2): 767-776. doi:10.1111/dom.16071
Author affiliation
College of Life Sciences
Population Health Sciences
The protocol, consent form, definition and derivation of clinical characteristics and outcomes, training materials, regulatory documents, information about requests for data access, and other relevant study materials are available online.